Attempt to Establish an Experimental Animal Model of Moyamoya Disease Using Immuno-embolic Material - Histological Changes of the Arterial Wall Resulting from Immunological Reaction in Cats -

Acta Medica Okayama

Volumn 57, Issue 3, 2003, Pages 143-150

  Kamata, Ichiro ^a   Terai, Yoshinori ^a   Ohmoto, Takashi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Embolization; Etiology; Histology; Immunological reaction; Moyamoya disease

Indexed keywords

GLYCOLIC ACID; LACTIC ACID; MURAMYL DIPEPTIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE;

ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA; ARTERY WALL; ARTICLE; CAT; COMMON CAROTID ARTERY; CONTROLLED STUDY; EXPERIMENTAL MODEL; IMMUNOREACTIVITY; INTERNAL CAROTID ARTERY; INTERNAL CAROTID ARTERY OCCLUSION; MOYAMOYA DISEASE; NONHUMAN;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ADJUVANTS, IMMUNOLOGIC; ANIMALS; CAROTID ARTERIES; CAROTID ARTERY, COMMON; CAROTID ARTERY, INTERNAL; CATS; CEREBRAL ANGIOGRAPHY; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; INJECTIONS, INTRA-ARTERIAL; LACTIC ACID; MOYAMOYA DISEASE; POLYGLYCOLIC ACID; POLYMERS; TUNICA INTIMA;

ANIMALIA; FELIS CATUS;

EID: 0242489026     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Suzuki J and Takaku A: Cerebrovascular "moyamoya" disease: Disease showing abnormal net-like vessels in base of brain. Arch Neurol (1969) 20: 288-299.
2. Kudo T: Spontaneous occlusion of the circle of Willis: A disease apparently confined to Japanese. Neurology (1968) 18: 485-496.
3. Nishimoto A and Takeuchi S: Abnormal cerebrovascular network related to the internal carotid arteries. J Neurosurg (1968) 29: 255-260.
4. Ikeda E and Hosoda Y: Distribution of thrombotic lesions in the cerebral arteries in spontaneous occlusion of the circle of Willis: Cerebrovascular moyamoya disease. Clin Neuropathol (1993) 12: 44-48
5. Suzuki J and Takaku A: Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol (1969) 20: 288-299
6. Hosoda Y, Kuramochi S, Matsuyama J, Sakamoto M and Yoshimura Y: An immunohistochemical study of cerebral and systemic arteries in autopsy cases with spontaneous occlusion of the circle of Willis; in Annual Report (1986) of the Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan (Chairman, Handa H) (1987) pp 74-77 (in Japanese).
7. Haltia M, Iivanainen M, Majuri H and Puranen M: Spontaneous occlusion of the circle of Willis (moyamoya syndrome). Clin Neuropathol (1982) 1: 11-22.
8. Yamashita M, Oka K and Tanaka K: Histopathology of the brain vascular network in moyamoya disease. Stroke (1983) 14: 50-58.
9. Hosoda Y: Pathology of so-called "spontaneous occlusion of the circle of Willis". Pathol Annu (1984) 19: 221-244.
10. Takebayashi S, Matsuo K and Kaneko M: Ultrastructural studies of cerebral arteries and collateral vessels in moyamoya disease. Stroke (1984) 15: 728-732.
11. Aoyagi M, Fukai N, Matsushima Y, Yamamoto M and Yamamoto K: Kinetics of 1251-PDGF binding and down-regulation of PDGF receptor in arterial smooth muscle cells derived from patients with moyamoya disease. J Cell Physiol (1993) 154: 281-288.
12. Hoshimaru M, Takahashi JA, Kikuchi H, Nagata I and Hatanaka M: Possible roles of basic fibroblast growth factor in the pathogenesis of moyamoya disease: An immunohistochemical study. J Neurosurg (1991) 75: 267-270.
13. Hojo M, Hoshimaru M, Miyamoto S, Taki W, Nagata I, Asahi M, Matsuura N, Ishizaki R, Kikuchi H and Hashimoto N: Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease. J Neurosurg (1998) 89: 623-629.
14. Kitahara T, Ariga N, Yamaura A, Makino H and Maki Y: Familial occurrence of Moyamoya disease: Report of three Japanese families. J Neurol Neurosurg Psychiatry (1979) 42: 208-214.
15. Houkin K, Tanaka N, Takahashi A, Kamiyama H, Abe H and Kajii N: Familial occurrence of Moyamoya disease. Magnetic resonance angiography as a screening test for high-risk subjects. Childs Nerv Syst (1994) 10: 421-425.
16. Ikeda H, Sasaki T, Yoshimoto T, Fukui M and Arinami T: Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet (1999) 64: 533-537.
17. Suzuki J and Kodama N: Cerebrovascular "Moyamoya" disease. Second report: Collateral routes to forebrain via ethmoid sinus and superior nasal meatus. Angiology (1971) 22: 223-236.
18. Kasai N, Fujiwara S, Kodama N, Yonemitsu T and Suzuki J: The experimental study on causal genesis of Moyamoya disease: correlation with immunological reaction and sympathetic nerve influence for vascular changes. Noushinkeigeka (1982) 10: 251-261 (in Japanese).
19. Suzuki J, Yonematsu T, Ezura M and Fujiwara S: Experimental study on etiology of Moyamoya disease: Effects of bacterial cell wall on cerebral artery; in Annual Report (1986) of the Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan (Chairman, Handa H) (1987) pp 57-62 (in Japanese).
20. Ezura M, Fujiwara S, Nose M, Yoshimoto T and Kyogoku M: Attempts to induce immune-mediated cerebral arterial injury for an experimental model of moyamoya disease. Childs Nerv Syst (1992) 8: 263-267
21. Yamada H, Deguchi K, Tanigawara T, Takenaka K, Nishimura Y, Shinoda J, Hattori T, Andoh T and Sakai N: The relationship between moyamoya disease and bacterial infection. Clin Neurol Neurosurg (1997) 99: S221-S224
22. Chedid L, Audibert F, Lefrancier P, Choay J and Lederer E: Modulation of the immune response by a synthetic adjuvant and analogs. Proc Natl Acad Sci USA (1976) 73: 2472-2475.
23. Kotani S and Takada H: Immunopharmacological activities of bacterial cell walls and related synthetic compounds (Muramyl Peptides). Yakugaku Zasshi (Journal of the Pharmaceutical Society of Japan) (1983) 103: 1-27 (in Japanese).
24. Sato S and Suzuki J: Anatomical mapping of the cerebral nervi vasorum in the human brain. J Neurosurg (1975) 43: 559-568
25. Furuta K, Homma T, Yoshioka J, Tamura Y, Hirabayashi H, Sasaki Y, Kawa S, Monno S, Hara T and Furuta S: A case of moyamoya disease associated with stenosis of the right coronary artery, sick sinus syndrome and hypertrophic cardiomyopathy. Kokyu To Junkan (Respiration & Ciruculation) (1985) 33: 1401-1406 (in Japanese).
26. Tokunaga Y, Toyoda K, Ago T, Ibayashi S, Usui M and Fujishima M: Systemic vascular change associated with moyamoya-like cerebrovascular disease and microvascular coronary artery disease. Rinsho Shinkeigaku (Clin Neurol) (1996) 36: 318-322 (in Japanese).
27. Akasaki T, Kagiyama S, Omae T, Ohya Y, Ibayashi S, Abe I and Fujishima M: Asymptomatic moyamoya disease associated with coronary and renal artery stenoses - a case report. Jpn Circ J (1998) 62: 136-138.
28. Nakano T, Azuma E, Ido M, Itoh M, Sakurai M, Suga S and Kawaguchi H: Moyamoya disease associated with bilateral renal artery stenosis. Acta Paediatr Jpn (1993) 35: 354-357.
29. Yamada I, Himeno Y, Matsushima Y and Shibuya H: Renal artery lesions in patients with moyamoya disease: Angiographic findings. Stroke (2000) 31: 733-737.
30. Ikeda E: Systemic vascular changes in spontaneous occlusion of the circle of Willis. Stroke (1991) 22: 1358-1362.